UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039753
Receipt number R000045304
Scientific Title Effects of fig tea on atopic dermatitis. Placebo-controlled, double-blind, randomized trial
Date of disclosure of the study information 2021/07/07
Last modified on 2022/10/31 17:02:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of fig tea on atopic dermatitis.
Placebo-controlled, double-blind, randomized trial

Acronym

Atopic dermatitis inhibitory effects of fig tea.

Scientific Title

Effects of fig tea on atopic dermatitis.
Placebo-controlled, double-blind, randomized trial

Scientific Title:Acronym

Atopic dermatitis inhibitory effects of fig tea.

Region

Japan


Condition

Condition

Atopic dermatitis

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of fig tea on atopic dermatitis symptoms is evaluated by a placebo-controlled double-blind randomized trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Differences in the symptoms of atopic dermatitis between the test food group and the control food group were determined by the EASI (Eczema Area and Severity Index), blood biochemical tests, POEM (Patient-Oriented Eczema Measure) at 4, 8, and 12 weeks after ingestion.

Key secondary outcomes

VAS Quetionnaire (Skin condition, Itch, Medical Condition)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Drink 500 mL of fig tea daily for 8 weeks.

Interventions/Control_2

Drink 500 mL of water daily for 8 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Person who have mild symptoms of atopic dermatitis.

Key exclusion criteria

1) Person who has a history of diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disease, other severe disease.
2) Person who has food or medicine allergy.
3) Person who plan to use medicines due to atopic dermatitis.
4) Anemia patients.
5) Overdose of alcohol.
6) Those who are planning to become pregnant or breast-feeding during the examination period.
7) Participants in other clinical trials or those planning to participate.
8) Person who the attending physician determines inappropriate.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Miura

Organization

Miura Clinic, Medical Corporation Kanonkai

Division name

Internal medicine

Zip code

530-0044

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka-shi, Osaka, Japan

TEL

06-6135-5200

Email

info@miura-cl.jp


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Abe

Organization

Toyo institute of food technology

Division name

Research department

Zip code

666-0026

Address

23-2, 4chome, Minami-Hanayashiki, Kawanishi-shi, Hyogo, Japan

TEL

072-740-3300

Homepage URL


Email

tatsuya_abe@shokuken.or.jp


Sponsor or person

Institute

Miura Clinic, Medical Corporation Kanonkai

Institute

Department

Personal name



Funding Source

Organization

Toyo institute of food technology

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research etichs committee of Miura Clinic, Medical Corporation Kanonkai

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka-shi, Osaka, Japan

Tel

06-6135-5200

Email

mterashima@miura-cl.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人花音会みうらクリニック(大阪府)


Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 07 Day


Related information

URL releasing protocol

https://www.shokuken.or.jp/docs/business_report_2020.pdf

Publication of results

Unpublished


Result

URL related to results and publications

https://www.shokuken.or.jp/docs/business_report_2020.pdf

Number of participants that the trial has enrolled

30

Results

A double-blind randomized controlled trial (RCT) was conducted in patients with mild atopic dermatitis (AD). The test group received fig tea and the control group received water for 8 weeks, and the changes in AD symptoms were evaluated (15 subjects /group). The EASI score was significantly decreased by the continuous intake of fig tea compared to the water group. In addition, the fig tea group showed a significant decrease in AST (OGT) and LDH, an indicator of liver function, and a decreasing trend in ALP.

Results date posted

2021 Year 08 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

mild atopic dermatitis (EASI score:1.3-15.0)

Participant flow

30 subjects were selected from 88 candidates based on EASI score

Adverse events

N/A

Outcome measures

Physician visual assessment with atopic dermatitis (EASI score)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 02 Month 18 Day

Date of IRB

2020 Year 02 Month 21 Day

Anticipated trial start date

2020 Year 03 Month 17 Day

Last follow-up date

2020 Year 07 Month 08 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 10 Day

Last modified on

2022 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045304


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name